Prevention or early treatment of preeclampsia

Article Abstract:

More research is needed on the exact cause of preeclampsia so effective treatments can be given early in pregnancy. Preeclampsia is characterized by high blood pressure and protein in the urine. Blood supply to almost every organ, including the placenta, is reduced. This suggests that it is caused by a disorder of the blood vessels. Signs of the disorder can be detected weeks to months before delivery, allowing for early treatment. Many treatments are designed to lower blood pressure but preventing damage to the fetus may be a more important goal. Calcium supplements and aspirin may be beneficial in preventing adverse outcomes.

Calcium (Nutrient), Aspirin, Calcium, Dietary

---

Treatment of hypertension in pregnant women

Article Abstract:

Hypertension is a common complication of pregnancy and a potentially dangerous one if it occurs as a part of preeclampsia. Women who have a history of hypertension before pregnancy or who develop it before the 20th week have a very good prognosis and can be managed with antihypertensive drugs. Gestational hypertension occurs after the 20th week in a woman with normal blood pressure and does not require treatment. Preeclampsia is the combination of hypertension, protein in the urine and swelling occurring after the 20th week. It does not always respond to drugs and so a speedy delivery is the best treatment.

Hypertension in pregnancy, Gestational hypertension

---

Thrombophilias and adverse outcomes of pregnancy -- what should a clinician do?

Article Abstract:

More research is needed before obstetricians should recommend anticoagulants for women with blood clotting disorders. A 1998 study found that pregnant women who developed certain complications during childbirth were more likely to have gene mutations that caused blood clotting disorders. However, 17% of the women who did not have complications during childbirth also had the mutations. This indicates that not every woman with the mutations will develop complications during childbirth. However, women with a history of such complications who also have the mutations might benefit from anticoagulant medication.

Prevention, Complications and side effects, Gene mutations, Gene mutation, Blood clotting disorders, Blood coagulation disorders, Pregnancy, Complications of, Pregnancy complications

Similar abstracts:

• Abstracts: Predictors of antiretroviral treatment failure in an Urban HIV clinic. In vitro and in vivo: The story of nonoxynol 9
• Abstracts: Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load
• Abstracts: The essential fatty acid status of mother and child in pregnancy-induced hypertension: a prospective longitudinal study
• Abstracts: Revolutionary breast cancer treatments under study. Here comes the sun. Cancer center addresses emotions of genetic testing
• Abstracts: Potential health effects of the dietary flavonol quercetin. Beta-carotene, vitamin E and vitamin C in different stages of experimental carcinogenesis

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.